technetium tc 99m sestamibi has been researched along with Low Bone Density in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wang, Q; Zhao, Y | 1 |
Dong, F; Jia, Q; Meng, Z; Tan, J; Zhang, F; Zhang, M | 1 |
Antón, A; Caballero, O; Martínez, A; Serrano, J; Verdú, J | 1 |
Udelsman, R | 1 |
1 review(s) available for technetium tc 99m sestamibi and Low Bone Density
Article | Year |
---|---|
Primary hyperparathyroidism.
Topics: Adenocarcinoma; Adenoma; Bone Diseases, Metabolic; Calcitonin; Diagnostic Imaging; Diphosphonates; Diuretics; Feedback; Fluid Therapy; Furosemide; Humans; Hypercalcemia; Hyperparathyroidism; Hyperplasia; Kidney; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Parathyroidectomy; Phosphates; Radiopharmaceuticals; Surgery, Computer-Assisted; Technetium Tc 99m Sestamibi | 2001 |
3 other study(ies) available for technetium tc 99m sestamibi and Low Bone Density
Article | Year |
---|---|
Bone uptake of Tc-99m MIBI in patients with hyperparathyroidism.
Topics: Adolescent; Adult; Aged; Alkaline Phosphatase; Blood Chemical Analysis; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Calcium; Female; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Whole Body Imaging; Young Adult | 2014 |
Tc-99m pertechnetate/sestamibi imaging in a case of recurrent parathyroid carcinoma with metabolic bone disorder.
Topics: Aged; Bone Diseases, Metabolic; Calcium; Carcinoma; Humans; Male; Neoplasm Recurrence, Local; Parathyroid Hormone; Parathyroid Neoplasms; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Sestamibi | 2009 |
[Reversible hyperparathyroid metabolic osteopathy secondary to parathyroid carcinoma].
Topics: Bone and Bones; Bone Diseases, Metabolic; Carcinoma; Contrast Media; Follow-Up Studies; Humans; Hyperparathyroidism, Secondary; Male; Middle Aged; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Technetium Tc 99m Sestamibi; Time Factors | 1998 |